Literature DB >> 20874666

In vitro evaluation of a targeted and sustained release system for retinoblastoma cells using Doxorubicin as a model drug.

Sai H S Boddu1, Jwala Jwala, Monica R Chowdhury, Ashim K Mitra.   

Abstract

PURPOSE: The objective of this study was to develop a novel folate receptor-targeted drug delivery system for retinoblastoma cells using doxorubicin (DOX) as a model drug.
METHODS: Biodegradable DOX-loaded poly(d,l-lactide-co-glycolide)-poly(ethylene glycol)-folate (PLGA-PEG-FOL) micelles (DOXM) were prepared with various solvents (dimethylsulfoxide, acetone, and dimethylformamide). The effects of solvents on entrapment efficiency, particle size, and polydispersity were examined. The effects of thermosensitive gel structure on the release of DOX from the DOXM were also studied. Qualitative and quantitative uptake studies of DOX and DOXM were carried out in Y-79 cell line. Cytotoxicity studies of DOXM were performed on Y-79 cells.
RESULTS: Based on size, polydispersity, and entrapment efficiency, dimethylformamide was found to be the most suitable solvent for the preparation of DOXM. Dispersion of DOXM in PLGA-PEG-PLGA gel sustained drug release for a period of 2 weeks. Uptake of DOX was ∼4 times higher with DOXM than DOX in Y-79 cells overexpressing folate receptors. This was further confirmed from the quantitative uptake studies. DOXM exhibited higher cytotoxicity in Y-79 cells when compared with pure DOX.
CONCLUSION: These polymeric micellar systems suspended in thermosensitive gels may provide sustained and targeted delivery of anticancer agents to retinoblastoma cells following intravitreal administration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874666      PMCID: PMC2956377          DOI: 10.1089/jop.2010.0048

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  39 in total

Review 1.  Management of advanced retinoblastoma.

Authors:  Santosh G Honavar; Arun D Singh
Journal:  Ophthalmol Clin North Am       Date:  2005-03

Review 2.  Novel approaches to retinal drug delivery.

Authors:  Kumar G Janoria; Sriram Gunda; Sai H S Boddu; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2007-07       Impact factor: 6.648

3.  Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.

Authors:  S Q Liu; Y W Tong; Yi-Yan Yang
Journal:  Biomaterials       Date:  2005-08       Impact factor: 12.479

4.  Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery.

Authors:  Eun Kyoung Park; So Yeon Kim; Sang Bong Lee; Young Moo Lee
Journal:  J Control Release       Date:  2005-11-02       Impact factor: 9.776

5.  Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.

Authors:  Sridhar Duvvuri; Kumar Gaurav Janoria; Ashim K Mitra
Journal:  J Control Release       Date:  2005-10-17       Impact factor: 9.776

Review 6.  Roles of multidrug resistance genes in breast cancer chemoresistance.

Authors:  M Tien Kuo
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

7.  Selectivity of folate conjugated polymer micelles against different tumor cells.

Authors:  Haizheng Zhao; Lin Yue Lanry Yung
Journal:  Int J Pharm       Date:  2007-08-06       Impact factor: 5.875

8.  Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.

Authors:  Sridhar Duvvuri; Kumar G Janoria; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2007-06       Impact factor: 2.671

Review 9.  Retinoblastoma: review of current management.

Authors:  Murali Chintagumpala; Patricia Chevez-Barrios; Evelyn A Paysse; Sharon E Plon; Richard Hurwitz
Journal:  Oncologist       Date:  2007-10

Review 10.  Retinoblastoma.

Authors:  Isabelle Aerts; Livia Lumbroso-Le Rouic; Marion Gauthier-Villars; Hervé Brisse; François Doz; Laurence Desjardins
Journal:  Orphanet J Rare Dis       Date:  2006-08-25       Impact factor: 4.123

View more
  5 in total

1.  Differential expression of folate receptor-alpha, sodium-dependent multivitamin transporter, and amino acid transporter (B (0, +)) in human retinoblastoma (Y-79) and retinal pigment epithelial (ARPE-19) cell lines.

Authors:  Jwala Jwala; Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Sai Hanuman Sagar Boddu; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2012-02-03       Impact factor: 2.671

Review 2.  Nanomedicines for back of the eye drug delivery, gene delivery, and imaging.

Authors:  Uday B Kompella; Aniruddha C Amrite; Rashmi Pacha Ravi; Shelley A Durazo
Journal:  Prog Retin Eye Res       Date:  2013-04-17       Impact factor: 21.198

3.  Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma.

Authors:  Hashem Alsaab; Rami M Alzhrani; Prashant Kesharwani; Samaresh Sau; Sai Hs Boddu; Arun K Iyer
Journal:  Pharmaceutics       Date:  2017-04-18       Impact factor: 6.321

Review 4.  Evolution of Nanotechnology in Delivering Drugs to Eyes, Skin and Wounds via Topical Route.

Authors:  Pratheeksha Koppa Raghu; Kuldeep K Bansal; Pradip Thakor; Valamla Bhavana; Jitender Madan; Jessica M Rosenholm; Neelesh Kumar Mehra
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-27

5.  Green Light-Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma.

Authors:  Kaiqi Long; Yang Yang; Wen Lv; Kuan Jiang; Yafei Li; Amy Cheuk Yin Lo; Wai Ching Lam; Changyou Zhan; Weiping Wang
Journal:  Adv Sci (Weinh)       Date:  2021-08-27       Impact factor: 16.806

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.